Given that, overexpression of cyclin D1 is correlated with tumor differentiation, poor survival, increased metastasis and resistance to certain cytotoxic drugs including tamoxifen [24–27] targeting cyclin D may be considered as an effective strategy for the treatment of chondrosarcoma. This evidence concerns the gene CCND1 and chondrosarcoma.